Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers-results from BPC3

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Lindstrom, Sara ^a   Schumacher, Fredrick ^b   Siddiq, Afshan ^c   Travis, Ruth C ^d   Campa, Daniele ^e   Berndt, Sonja I ^f   Diver, W Ryan ^g   Severi, Gianluca ^h   Allen, Naomi ^d   Andriole, Gerald ⁱ   Bueno de Mesquita, Bas ^j   Chanock, Stephen J ^f   Crawford, David ^k   Gaziano, J Michael ^l,m   Giles, Graham G ^h,n   Giovannucci, Edward ^a   Guo, Carolyn ^a   Haiman, Christopher A ^b   Hayes, Richard B ^f,o   Halkjaer, Jytte ^p   Hunter, David J ^a,m   Johansson, Mattias ^q,r   Kaaks, Rudolf ^e   Kolonel, Laurence N ^s   Navarro, Carmen ^t,u   Riboli, Elio ^c   Sacerdote, Carlotta ^v   Stampfer, Meir ^a,m   Stram, Daniel O ^b   Thun, Michael J ^g   Trichopoulos, Dimitrios ^a,w   Virtamo, Jarmo ^x   Weinstein, Stephanie J ^f   Yeager, Meredith ^f   Henderson, Brian ^b   Ma, Jing ^m   Le Marchand, Loic ^s   Albanes, Demetrius ^f   Kraft, Peter ^a   more..

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f NATIONAL CANCER INSTITUTE   (United States)

^g AMERICAN CANCER SOCIETY   (United States)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^k UNIVERSITY OF COLORADO   (United States)

^l VETERANS AFFAIRS MEDICAL CENTER   (United States)

^m BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁿ MONASH UNIVERSITY   (Australia)

^o NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^p INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^q INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^r UMEÅ UNIVERSITY   (Sweden)

^s UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^t Regional Health Authority   (Spain)

^u CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^v Human Genetics Foundation   (Italy)

^w WHO Collaborating Center for Food and Nutrition Policies   (Greece)

^x NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; PROTEIN KLK3; SERINE PROTEINASE; UNCLASSIFIED DRUG; TUMOR MARKER;

ALLELE; ARTICLE; BODY HEIGHT; BODY MASS; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; DIABETES MELLITUS; DRINKING BEHAVIOR; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; GLEASON SCORE; HUMAN; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; AGED; CARCINOMA; CASE CONTROL STUDY; COHORT ANALYSIS; ENVIRONMENT; GENE FREQUENCY; GENETIC EPISTASIS; GENETIC PREDISPOSITION; GENETICS; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROSTATE TUMOR; RISK FACTOR;

AGED; CARCINOMA; CASE-CONTROL STUDIES; COHORT STUDIES; ENVIRONMENT; EPISTASIS, GENETIC; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 79952086198     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017142     Document Type: Article

References (43)

1. Gronberg H, (2003) Prostate cancer epidemiology. Lancet 361: 859-864.
2. Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, et al. (2007) Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst 99: 1836-1844.
3. Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, et al. (2009) Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 41: 1116-1121.
4. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, et al. (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 40: 316-321.
5. Gudmundsson J, Sulem P, Gudbjartsson DF, Blondal T, Gylfason A, et al. (2009) Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet 41: 1122-1126.
6. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, et al. (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 39: 631-637.
7. Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, et al. (2008) Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 40: 281-283.
8. Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson JT, Thorleifsson G, et al. (2007) Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 39: 977-983.
9. Hsu FC, Sun J, Wiklund F, Isaacs SD, Wiley KE, et al. (2009) A novel prostate cancer susceptibility locus at 19q13. Cancer Res 69: 2720-2723.
10. Kote-Jarai Z, Easton DF, Stanford JL, Ostrander EA, Schleutker J, et al. (2008) Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev 17: 2052-2061.
11. Sun J, Zheng SL, Wiklund F, Isaacs SD, Li G, et al. (2009) Sequence variants at 22q13 are associated with prostate cancer risk. Cancer Res 69: 10-15.
12. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, et al. (2008) Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 40: 310-315.
13. Yeager M, Chatterjee N, Ciampa J, Jacobs KB, Gonzalez-Bosquet J, et al. (2009) Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet 41: 1055-1057.
14. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39: 645-649.
15. Zheng SL, Stevens VL, Wiklund F, Isaacs SD, Sun J, et al. (2009) Two independent prostate cancer risk-associated Loci at 11q13. Cancer Epidemiol Biomarkers Prev 18: 1815-1820.
16. Ahn J, Berndt SI, Wacholder S, Kraft P, Kibel AS, et al. (2008) Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet 40: 1032-1034; author reply 1035-1036.
17. Wiklund F, Zheng SL, Sun J, Adami HO, Lilja H, et al. (2009) Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer. Prostate 69: 419-427.
18. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, et al. (2006) Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci U S A 103: 14068-14073.
19. Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, et al. (2007) Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. J Natl Cancer Inst 99: 1525-1533.
20. Skolarus TA, Wolin KY, Grubb RL 3rd, (2007) The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer. Nat Clin Pract Urol 4: 605-614.
21. Kraft P, Yen YC, Stram DO, Morrison J, Gauderman WJ, (2007) Exploiting gene-environment interaction to detect genetic associations. Hum Hered 63: 111-119.
22. Kader AK, Sun J, Isaacs SD, Wiley KE, Yan G, et al. (2009) Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients. Prostate 69: 1195-1205.
23. Abrahamsson PA, Lilja H, Falkmer S, Wadstrom LB, (1988) Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands. Prostate 12: 39-46.
24. Lilja H, Ulmert D, Vickers AJ, (2008) Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat Rev Cancer 8: 268-278.
25. Gudmundsson J, Besenbacher S, Sulem P, Gudbjartsson DF, Olafsson I, et al. (2010) Genetic Correction of PSA Values Using Sequence Variants Associated with PSA Levels. Sci Transl Med Dec 15 2 (62): 62ra92.
26. Fitzgerald LM, Kwon EM, Koopmeiners JS, Salinas CA, Stanford JL, et al. (2009) Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features. Clin Cancer Res 15: 3231-3237.
27. Winckler W, Weedon MN, Graham RR, McCarroll SA, Purcell S, et al. (2007) Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes. Diabetes 56: 685-693.
28. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, et al. (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40: 638-645.
29. Stevens VL, Ahn J, Sun J, Jacobs EJ, Moore SC, et al. (2010) HNF1B and JAZF1 genes, diabetes, and prostate cancer risk. Prostate 70: 601-607.
30. Macinnis RJ, English DR, (2006) Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 17: 989-1003.
31. Huncharek M, Haddock S, Reid R, Kupelnick B, (2010) Smoking as a Risk Factor for Prostate Cancer: A Meta-Analysis of 24 Prospective Cohort Studies. Am J Public Health, Apr 100 (4): 693-701.
32. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G, (2001) A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 85: 1700-1705.
33. Siemiatycki J, Thomas DC, (1981) Biological models and statistical interactions: an example from multistage carcinogenesis. Int J Epidemiol 10: 383-387.
34. Hunter DJ, Riboli E, Haiman CA, Albanes D, Altshuler D, et al. (2005) A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer 5: 977-985.
35. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330: 1029-1035.
36. Calle EE, Rodriguez C, Jacobs EJ, Almon ML, Chao A, et al. (2002) The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer 94: 2490-2501.
37. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, et al. (2002) European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5: 1113-1124.
38. Giovannucci E, Pollak M, Liu Y, Platz EA, Majeed N, et al. (2003) Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. Cancer Epidemiol Biomarkers Prev 12: 84-89.
39. Kolonel LN, Altshuler D, Henderson BE, (2004) The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nat Rev Cancer 4: 519-527.
40. Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, et al. (2002) Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 94: 1099-1106.
41. Hayes RB, Reding D, Kopp W, Subar AF, Bhat N, et al. (2000) Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 21: 349S-355S.
42. Severi G, Morris HA, MacInnis RJ, English DR, Tilley WD, et al. (2006) Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15: 1137-1141.
43. R Development Core Team (2008) R: A language and environment for statistical computing, R Foundation for Statistical Computing, Vienna, Austria.